149 related articles for article (PubMed ID: 10080826)
1. CD30 in normal and neoplastic cells.
Chiarle R; Podda A; Prolla G; Gong J; Thorbecke GJ; Inghirami G
Clin Immunol; 1999 Feb; 90(2):157-64. PubMed ID: 10080826
[TBL] [Abstract][Full Text] [Related]
2. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
3. CD30: expression and function in health and disease.
Horie R; Watanabe T
Semin Immunol; 1998 Dec; 10(6):457-70. PubMed ID: 9826579
[TBL] [Abstract][Full Text] [Related]
4. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
6. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?
Jansen MP; Hopman AH; Bot FJ; Haesevoets A; Stevens-Kroef MJ; Arends JW; Jox A; Wolf J; Ramaekers FC; Schouten HC
J Pathol; 1999 Dec; 189(4):527-32. PubMed ID: 10629553
[TBL] [Abstract][Full Text] [Related]
7. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
[TBL] [Abstract][Full Text] [Related]
8. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
9. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease.
Wahl AF; Klussman K; Thompson JD; Chen JH; Francisco LV; Risdon G; Chace DF; Siegall CB; Francisco JA
Cancer Res; 2002 Jul; 62(13):3736-42. PubMed ID: 12097283
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
[TBL] [Abstract][Full Text] [Related]
11. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
12. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?
Menestrina F; Chilosi M; Scarpa A
Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592
[TBL] [Abstract][Full Text] [Related]
13. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
[TBL] [Abstract][Full Text] [Related]
14. Expression of the CD30 antigen in non-lymphoid tissues and cells.
Dürkop H; Foss HD; Eitelbach F; Anagnostopoulos I; Latza U; Pileri S; Stein H
J Pathol; 2000 Apr; 190(5):613-8. PubMed ID: 10727988
[TBL] [Abstract][Full Text] [Related]
15. Human embryonal epithelial cells of the developing small intestinal crypts can express the Hodgkin-cell associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.
Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Bolioti S; Tsiapali M; Verettas D; Tsikouras P; Chatzimichail A; Papadopoulos N
Theor Biol Med Model; 2005 Jan; 2():1. PubMed ID: 15644135
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of K-1 (CD-30) marker in Hodgkin's disease.
Shakoor KA; Saleh A; Khanzada MS
J Pak Med Assoc; 2002 Oct; 52(10):442-7. PubMed ID: 12553671
[TBL] [Abstract][Full Text] [Related]
17. The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoter.
Dürkop H; Oberbarnscheidt M; Latza U; Bulfone-Paus S; Hirsch B; Pohl T; Krause H; Hummel M; Stein H
J Pathol; 2000 Oct; 192(2):182-93. PubMed ID: 11004694
[TBL] [Abstract][Full Text] [Related]
18. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
19. CD30 molecule (Ki-1 Ag): more than just a marker of CD30+ lymphoma.
Pizzolo G; Romagnani S
Haematologica; 1995; 80(4):357-66. PubMed ID: 7590507
[No Abstract] [Full Text] [Related]
20. First Hodgkin cell line L428 and the CD30 antigen: their role for diagnostic and treatment of CD30-positive neoplasms.
Stein H; Diehl V
Hematol Oncol Clin North Am; 2014 Feb; 28(1):1-11. PubMed ID: 24287063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]